Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

Chronic Inflammatory Disease Clinical Trial

— SCORIC-A  

Official title:

Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05613712
• Other study ID #: 38RC22.0355
• Status: Recruiting
• Start date: February 11, 2023
• Est. completion date: February 11, 2024

Study information

• Verified date: March 2023
• Source: University Hospital, Grenoble
• Contact: Athan BAILLET, PU-PH
• Phone: 0476767082
• Email: abaillet[@]chu-grenoble.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Description:

In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Est. completion date: February 11, 2024
• Est. primary completion date: February 11, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Patient cohort :
• men and women over 18 years of age
• Informed volunteers who have consented to participate in the study
• have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
• have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
• Cohort of referring physicians :
• volunteers who received informed information and consented to participate in the study
• be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes

Exclusion Criteria:

• Patient cohort :
• psychiatric pathologies or history of behavioural disorders
• persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
• persons under guardianship or curatorship
• not affiliated to the social security system
• minors
• Refusal to participate by the patient and/or unreturned questionnaire
• Cohort of referring physicians:
• the physician is no longer the patient's referring physician
• refusal of the doctor to participate and/or questionnaire not returned

Related Conditions & MeSH terms

• Chronic Inflammatory Disease
• Rheumatic Diseases
• Rheumatic Fever

Intervention

Other:
• Patients
Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up
• Referring physician
Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes

Locations

Country	Name	City	State
France	CHU Grenoble Alpes	Grenoble

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires	Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes	1 day
Secondary	Elements limiting the good ambulatory follow-up, according to the patients	Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up	1 day
Secondary	Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients	Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes	1 day